0
Article |

Diphtheria and Tetanus Toxoids and Pertussis Vaccine Litigation FREE

HOWARD LOKIETZ, MD
[+] Author Affiliations

This department of AJDC is reserved for comment, criticism, observation, and discussion of issues of current concern and importance for children's health. The Editor encourages our readers to express themselves on a variety of topics and issues. Further, we encourage the submission of unique and brief clinical and scientific observations that do not fulfill the criteria for original articles.


Am J Dis Child. 1991;145(4):425. doi:10.1001/archpedi.1991.02160040081005.
Text Size: A A A
Published online

Sir.—Orenstein's letter,1 published in the May 1990 issue of AJDC, points out what is naive and bad in current thinking concerning litigation over the diphtheria and tetanus toxoids and pertussis vaccines. The National Vaccine Injury Compensation Program, effective October 1, 1988, was the most naive, if not the most stupid attempt at controlling a segment of our legal system that needs to be controlled. Intended to offer a good method of avoiding costly legal battles, it did just the opposite. Lawyers now have two recourses to sue. They can always sue if the National Vaccine Injury Compensation Program is not to their liking.

For the private sector, the program did nothing but increase our cost of the vaccine to approximately $17 per dose (not the $7.96 the government pays).

Numerous studies have indicated that the vaccine itself had nothing to do with the "brain damage" reported by attorneys

REFERENCES

Orenstein WA.  DTP vaccine litigation, 1988 . AJDC . 1990;;144:517.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Orenstein WA.  DTP vaccine litigation, 1988 . AJDC . 1990;;144:517.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.